Leukemia Research Journal

Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients

Fulltext Access 15 Pages 2018

Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line

Fulltext Access 9 Pages 2018

Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an admixed population in the Brazilian Amazon

Fulltext Access 4 Pages 2018

RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice

Fulltext Access 7 Pages 2018

TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia

Fulltext Access 26 Pages 2018

NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells

Fulltext Access 7 Pages 2018

Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow

Fulltext Access 20 Pages 2018

An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function

Fulltext Access 7 Pages 2018

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy

Fulltext Access 5 Pages 2018

Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy

Fulltext Access 6 Pages 2018

Clustered incidence of adult acute promyelocytic leukemia

Fulltext Access 11 Pages 2018

TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid

Fulltext Access 4 Pages 2018

Does switching to a second-generation tyrosine kinase inhibitor or increasing imatinib dose have long-term benefits in chronic myeloid leukemia patients with suboptimal responses under upfront standard-dose of imatinib?

Fulltext Access 10 Pages 2018

Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS

Fulltext Access 21 Pages 2018